Independent Validation and Acceptance
Your dedicated, proven package for independent verification and acceptance of the Varian® Halcyon™/Ethos™️ 1) as well as for monthly and annual scans.
myQA HALO™ is your dedicated, proven package solution for independent verification and acceptance of the Varian® Halcyon™/Ethos™️ 1) as well as for monthly and annual scans.
The myQA HALO™ package consists of leading-edge Beam Scanning components that are released, clinically implemented, and trusted by over 4,000 satisfied users worldwide!
- Package for independent verification & acceptance of the Varian® Halcyon™/Ethos™️
- myQA Accept: Beam Scanning integrated in the myQA® Platform
- Blue Phantom: The right fit for Halcyon™/Ethos™️ 1) validation & required scans
- Stealth Chamber: Small Field scanning accuracy with ease
myQA HALO™️ used to commission Varian® Halcyon™ /Ethos™️ 1) in one day
myQA HALO™️ independent commissioning solution enables the Radiation Oncology Center at MedStar Southern Maryland Hospital Center fast clinical implementation of a Varian® Halcyon™/Ethos™️ 1)
IBA Dosimetry Solution used to accept the First Varian® Halcyon™/Ethos™️ 1) in the United States
IBA Dosimetry QA solutions used at The University of Pennsylvania to accept their new Halcyon™/Ethos™ linear accelerator.
Chris Kennedy Ph.D. DABR, Medical Physicist at UPENN: “We had a very good experience using our Blue Phantom solution to validate our Halcyon™/Ethos™ Linac. We actually used the same equipment that Varian® used when they did their original commissioning of the treatment planning system. The setup was very straightforward, and the flexibility of the myQA Accept software was essential for aligning the detector using the image-based methods necessary for Halcyon. The bulk of our validation work was done in 3 days.”
Find more QA solutions for the Varian® Halcyon™/Ethos™ 1) :
1 All product and company names are trademarks or registered trademarks of their respective holders. Use of them does not imply any relationship, sponsorship, or endorsement between IBA or its products and the owners of these trademarks.